Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

(2018) Philip McGuire et al.   AMERICAN JOURNAL OF PSYCHIATRY

Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain

(2018) Mariana C. Diana et al.   CNS Neuroscience & Therapeutics

Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex

(2018) Amanda J. Sales et al.   MOLECULAR NEUROBIOLOGY

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

(2018) Douglas L. Boggs et al.   PSYCHOPHARMACOLOGY

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

(2018) Fernanda F. Peres et al.   Frontiers in Pharmacology

How gender affects the pharmacotherapeutic approach to treating psychosis – a systematic review

(2017) Bettina Lange et al.   EXPERT OPINION ON PHARMACOTHERAPY

Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model

(2017) Ashleigh L Osborne et al.   NEUROPSYCHOPHARMACOLOGY

Fear memory in a neurodevelopmental model of schizophrenia based on the postnatal blockade of NMDA receptors

(2017) Joachim Latusz et al.   Pharmacological Reports

Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia

(2017) Marco Aurélio Mori et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders

(2017) Alline C. Campos et al.   Frontiers in Pharmacology

Prediction of conversion to psychosis: review and future directions

(2017) Dylan G. Gee et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Impaired contextual fear-conditioning in MAM rodent model of schizophrenia

(2017) Kathryn M. Gill et al.   SCHIZOPHRENIA RESEARCH

Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice

(2016) Andreza B. Sonego et al.   BEHAVIOURAL BRAIN RESEARCH

Associations of attention-deficit/hyperactivity and other childhood disorders with psychotic experiences and disorders in adolescence

(2016) Timo Hennig et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action

(2016) Maurício dos-Santos-Pereira et al.   NEUROBIOLOGY OF DISEASE

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors

(2016) Raquel Linge et al.   NEUROPHARMACOLOGY

Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder

(2016) M. Lambert et al.   PHARMACOPSYCHIATRY

Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia

(2016) F.F. Peres et al.   SCHIZOPHRENIA RESEARCH

Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model

(2016) Camila Mauricio Santos et al.   SCHIZOPHRENIA RESEARCH

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

(2016) Fernanda F. Peres et al.   Frontiers in Pharmacology

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence

(2016) Cathrin Rohleder et al.   Frontiers in Pharmacology

Serotonin 5-HT1A Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs

(2015) Andrew McCreary et al.   CURRENT PHARMACEUTICAL DESIGN

Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria

(2015) A.C. Campos et al.   NEUROSCIENCE

Molecular Targets of Cannabidiol in Neurological Disorders

(2015) Clementino Ibeas Bih et al.   Neurotherapeutics

Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)

(2015) Luiza Reali Nazario et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study

(2014) Kim Donoghue et al.   PSYCHIATRY RESEARCH

Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain

(2014) Valéria Almeida et al.   SCHIZOPHRENIA RESEARCH

N-acetylcysteine prevents increased amphetamine sensitivity in social isolation-reared mice

(2014) Ana P. Herrmann et al.   SCHIZOPHRENIA RESEARCH

Comorbidity of schizophrenia and adult attention-deficit hyperactivity disorder

(2014) Rossen Donev et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain

(2014) Raquel Levin et al.   Frontiers in Pharmacology

Prediction and prevention of the first psychotic episode: new directions and opportunities

(2014) Giorgio Marchese et al.   Therapeutics and Clinical Risk Management

The contextual brain: implications for fear conditioning, extinction and psychopathology

(2013) Stephen Maren et al.   NATURE REVIEWS NEUROSCIENCE

Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors

(2013) M. Ruth Pazos et al.   NEUROPHARMACOLOGY

Olanzapine Treatment of Adolescent Rats Causes Enduring Specific Memory Impairments and Alters Cortical Development and Function

(2013) Jean A. Milstein et al.   PLoS One

Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice

(2013) Felipe V. Gomes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia

(2012) Raquel Levin et al.   CURRENT PHARMACEUTICAL DESIGN

Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis

(2012) Tatiana Barichello et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors

(2012) Alline Cristina Campos et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test

(2012) Valéria Almeida et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Negative symptoms in individuals at clinical high risk of psychosis

(2012) Danijela Piskulic et al.   PSYCHIATRY RESEARCH

The Psychosis High-Risk State

(2012) Paolo Fusar-Poli et al.   JAMA Psychiatry

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.

(2011) Gislaine Z. Réus et al.   ACTA NEUROPSYCHIATRICA

Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats

(2011) Mariana Bendlin Calzavara et al.   BEHAVIOURAL BRAIN RESEARCH

To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models

(2011) Urs Meyer et al.   NEUROPHARMACOLOGY

Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine

(2011) Raquel Levin et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Anxiogenic-like effects of chronic cannabidiol administration in rats

(2011) Maha M. ElBatsh et al.   PSYCHOPHARMACOLOGY

Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture

(2010) Omar J. Cassol-Jr et al.   BRAIN RESEARCH

Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation

(2010) I Magen et al.   BRITISH JOURNAL OF PHARMACOLOGY

Rethinking schizophrenia

(2010) Thomas R. Insel   NATURE

Cognition in transmembrane domain neuregulin 1 mutant mice

(2010) L. Duffy et al.   NEUROSCIENCE

Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

(2010) Abir T. El-Alfy et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Risperidone Administered During Asymptomatic Period of Adolescence Prevents the Emergence of Brain Structural Pathology and Behavioral Abnormalities in an Animal Model of Schizophrenia

(2010) Y. Piontkewitz et al.   SCHIZOPHRENIA BULLETIN

Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future

(2010) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Clozapine Administration in Adolescence Prevents Postpubertal Emergence of Brain Structural Pathology in an Animal Model of Schizophrenia

(2009) Yael Piontkewitz et al.   BIOLOGICAL PSYCHIATRY

Adolescent and Adult Male Spontaneous Hyperactive Rats (SHR) Respond Differently to Acute and Chronic Methylphenidate (Ritalin)

(2009) Elyssa Barron et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Cannabidiol for the treatment of psychosis in Parkinson’s disease

(2008) AW Zuardi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

(2008) Neal R. Swerdlow et al.   PSYCHOPHARMACOLOGY

Neuroleptic Drugs Revert the Contextual Fear Conditioning Deficit Presented by Spontaneously Hypertensive Rats: A Potential Animal Model of Emotional Context Processing in Schizophrenia?

(2008) M. B. Calzavara et al.   SCHIZOPHRENIA BULLETIN

Evaluating Early Preventive Antipsychotic and Antidepressant Drug Treatment in an Infection-Based Neurodevelopmental Mouse Model of Schizophrenia

(2008) U. Meyer et al.   SCHIZOPHRENIA BULLETIN

Uncontrollable voices and their relationship to gating deficits in schizophrenia

(2008) Veena Kumari et al.   SCHIZOPHRENIA RESEARCH

Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats

(2007) J. De Ross et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY